Scaling recombinant enzyme biomanufacturing, oral substrate reduction therapeutics, and early genomic screening is propelling expansion across the global Gaucher Disease Treatment Market. Gaucher disease therapies restore metabolic balance in patients suffering from lysosomal storage disorders caused by glucocerebrosidase (GCase) deficiency. Academic medical centers, rare disease clinical...